9969 fundamentals
An in-depth look to INNOCARE PHARMA LTD operating, investing, and financing activities
9969 free cash flow for Q4 24 is -733.91 M HKD. For 2024, 9969 free cash flow was -336.14 M HKD and operating cash flow was -251.32 M HKD.
Q3 '18
Q4 '18
Q3 '19
Q4 '19
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q3 '18
Q4 '18
Q3 '19
Q4 '19
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM